IM Cannabis Secures US$225K in Highly Dilutive Convertible Note Financing
IMCC sits 41% above its 52-week low of $0.219.
Summary
IM Cannabis Corp. closed a US$225,000 convertible note and warrant financing with highly dilutive terms, providing essential capital for general corporate purposes amidst a going concern warning and Nasdaq delisting risk.
Key Events · Financing and Capital Events · IMCC
-
Convertible Note Financing Closed
IM Cannabis Corp. closed a US$225,000 convertible note financing, receiving US$202,500 in net proceeds for general corporate purposes.
-
Highly Dilutive Conversion Terms
The convertible note has a fixed conversion price of US$0.288 per share (below current market price) or 90% of the lowest daily VWAP, subject to a US$0.0576 floor price, indicating significant potential dilution.
-
Warrants Issued
The company issued warrants to purchase up to 781,250 common shares at an exercise price of CAD$0.40 per share, adding further potential dilution.
-
Addresses Going Concern and Nasdaq Compliance
This financing follows a recent 'going concern' warning and a Nasdaq notification for failing to meet the minimum bid price requirement, highlighting the company's reliance on dilutive capital raises.
Analysis · IMCC · Life Sciences
IM Cannabis Corp. has secured US$225,000 in gross proceeds through a convertible note and warrant financing. This capital raise is critical for the company, which recently issued a going concern warning and received a Nasdaq non-compliance notice. However, the terms are highly dilutive, with a fixed conversion price below the current market price and a variable conversion price with a very low floor, alongside warrants. This indicates the company's urgent need for capital and its reliance on terms unfavorable to existing shareholders to maintain operations and address listing requirements.
At the time of this filing, IMCC was trading at $0.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $0.22 to $3.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.